Treatment course and follow-up
With the final diagnosis of PCL, the patient was started on the bortezomib, lenalidomide, dexamethasone (VRD) regimen. The patient was responding to the treatment. but unfortunately, after the third cycle of chemotherapy, the patient developed severe sepsis and passed away.